Search in:
 Please use only plain characters
 (e.g., e, o, c and not è, ö or ç)
 		 
   
  Author   or    Free text  
   
  Author list  


© 2009 Elsevier Ltd. All rights reserved.
 
    Joint ECCO 15 - 34TH ESMO
    Multidisciplinary Congress
BERLIN, 20 - 24 SEPTEMBER 2009

Search Results     
SEARCHED IN ABSTRACT BY FREE TEXT: "panitumumab"
Found: Abstract: 9 1 -  9   

Abstract 10LBA:
Randomized phase 3 study of panitumumab with FOLFOX4 compared to FOLFOX4 alone as 1st-line treatment (tx) for metastatic colorectal cancer (mCRC): the PRIME trial
J. Douillard ; S. Siena; J. Cassidy; J. Tabernero; R. Burkes; M.E. Barugel; Y. Humblet; D. Cunningham; M. Wolf; J.L. Gansert 		 

Abstract 14LBA:
Randomized phase 3 study of panitumumab with FOLFIRI vs FOLFIRI alone as second-line treatment (tx) in patients (pts) with metastatic colorectal cancer (mCRC)
M. Peeters ; T. Price; Y. Hotko; A. Cervantes; M. Ducreux; T. André; E. Chan; F. Lordick; A. Rong; J. Gansert 		 

Abstract I-59:
Understanding the genetic basis of resistance to EGFR targeted therapies to personalize colorectal cancer treatment
A. Bardelli 		 

Abstract P-6045:
Safety analysis of starpan (star-02) study with panitumumab, 5fluorouracil, oxaliplatin and concurrent radiotherapy in locally advanced rectal cancer
F. Di Fabio; C. Pinto; E. Maiello; S. Pini; T. Latiano; C. Aschele; C. Garufi; A. Bochicchio; D. Tassinari; A. Martoni 		 

Abstract P-6073:
Interim analysis of epidermal-growth factor receptor (EGFR) expression in a single-arm, phase II, first-line study (20060314) of panitumumab with FOLFIRI in the management of metastatic colorectal cancer (mCRC)
C. Koehne; R. Hofheinz; L. Mineur; H. Letocha; R. Greil; J. Thaler; E. Gamelin; E. Fernebro; L. Wright; M. Karthaus 		 

Abstract P-6083:
Final results from PRECEPT: efficacy and safety of second-line treatment with panitumumab and FOLFIRI in patients with metastatic colorectal cancer (mCRC)
A. Cohn; D.A. Smith; M.A. Neubauer; D. Richards; D.L. Watkins; K. Zhang; M. Yassine 		 

Abstract P-8514:
SPECTRUM, a phase III trial for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) receiving chemotherapy with or without panitumumab: interim pooled safety analysis
J. Stohlmacher; I. Davidenko; E. Winquist; L. Licitra; K. Skladowski; T.E. Ciuleanu; R.R. Kumar; P. Foa; J. Gansert; J.B. Vermorken 		 

Abstract P-8516:
A phase 2 randomized trial of radiotherapy (RT) plus panitumumab compared to chemoradiotherapy in patients with unresected, locally advanced squamous cell carcinoma of the head and neck (SCCHN): interim pooled safety analysis
J. Giralt; J.M. Trigo; S. Nuyts; M. Ozsahin; A.B. Markowitz; J. Daisne; K. Skladowski; C. Lonchay; P. Holeckova; M. Smitt 		 

Abstract P-8519:
A phase 2, randomized trial (CONCERT-1) of chemoradiotherapy with or without panitumumab in patients (pts) with unresected, locally advanced squamous cell carcinoma of the head and neck (SCCHN): Interim pooled safety analysis
A. Fortin; A. Cmelak; R. Mesia; H. Minn; A.T.C. Chan; A.C. Yunes; M.C. Merlano; S. Singh; M. Smitt; M. Henke